| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 10/20/2004 | EP1468020A2 Multimers of receptor-binding ligands |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1468014A2 Compositions and methods for wt1 specific immunotherapy |
| 10/20/2004 | EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS |
| 10/20/2004 | EP1467747A2 Use of dimer-specific nuclear localisation signal peptides (dsnls) derived from the stat dna binding domain |
| 10/20/2004 | EP1467625A1 Adhesion inhibition of moulds |
| 10/20/2004 | EP1467615A1 Methods to engineer mammalian-type carbohydrate structures |
| 10/20/2004 | EP1212337B1 Pesticidal macrolides |
| 10/20/2004 | EP0967271B1 Novel carbonyl reductase, gene that encodes the same, and method of utilizing these |
| 10/20/2004 | EP0959895B1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
| 10/20/2004 | EP0886644B1 Long wavelength engineered fluorescent proteins |
| 10/20/2004 | EP0880590B1 Esterases |
| 10/20/2004 | EP0859050B1 Alkaline protease, process for the production thereof, use thereof, and microorganism producing the same |
| 10/20/2004 | EP0734451B1 ENTEROTOXINS OF SHIGELLA FLEXNERI 2a |
| 10/20/2004 | EP0722461B1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences |
| 10/20/2004 | EP0668906B1 Method for producing polypeptide via bacterial fermentation |
| 10/20/2004 | EP0631620B1 Mutagenesis and selection methoden in the same host cells |
| 10/20/2004 | CN1539018A Surface expression vectors having pgs BCA the gene coding poly-gamma-glutamate synthetase, and method for expression of target protein at the surface of microorganism using the vector |
| 10/20/2004 | CN1539017A Saponin-digesting enzymes, genes there of and soyasapogenol B mass procution system |
| 10/20/2004 | CN1539015A Production of L-lysine by genetically modified corynebacterium glutamicum strains |
| 10/20/2004 | CN1539010A Fermentation product of cryptoporus volvatus and its preparation method and application |
| 10/20/2004 | CN1538854A Mutant forms of cholera holotoxin as adjuvant |
| 10/20/2004 | CN1538853A T cell regulatory genes and methods of use thereof |
| 10/20/2004 | CN1537935A 培养物 Culture |
| 10/20/2004 | CN1172003C Method for producing N-acetylneuraminic acid |
| 10/20/2004 | CN1172001C Process for efficiently purifying gene engineering bacteria recombination expression product and its use |
| 10/20/2004 | CN1171997C Modified TLE-2-receptor ligands |
| 10/20/2004 | CN1171996C American pig reproduction and respiratory syndrome syndrome (PRRS) virus and its use |
| 10/20/2004 | CN1171993C Novel genes coding amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and their use |
| 10/20/2004 | CN1171900C Novel, ubiquitous potassium-channel proteins and genes for the same |
| 10/20/2004 | CN1171633C Cordyceps capsule and its preparation method |
| 10/20/2004 | CN1171631C Gamma & T cell immunoactivity potentiators containing shiitake mushroom hypha extract |
| 10/20/2004 | CN1171521C Method of culturing mycellium by using grain, its product use for culturing product |
| 10/19/2004 | US6806083 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis, heart defects, high blood pressure and stroke |
| 10/19/2004 | US6806068 Nucleotide sequences which encode the pfk gene |
| 10/19/2004 | US6806066 Plasmid which prolongs bacterial viability during fermentation |
| 10/19/2004 | US6806063 Protein conjugate for use in the treatment of blood disorder |
| 10/19/2004 | US6806059 Nucleotide sequences coding enzymatic polypeptide for use innthe treatment of asthma, and for use in laundry detergent and stain removers |
| 10/19/2004 | US6805868 Isolated, recombinant polypeptide comprising member selected from specified amino acid sequence and immunogenic fragment of at least 15 contiguous amino acids of that sequence; induces antibody or t-cell mediated immune response when administered |
| 10/19/2004 | US6805859 To provide a plant not showing livestock toxicity due to symbiotic fungi with which it is infected, and having strong resistance to pests, symbiotic fungus |
| 10/19/2004 | US6805800 Absorbing or adsorbing fat soluble compound from aqueous solution on fluidized bed of crystalline metallic ore particles to form complex, collecting complex from upper zone of bed, contacting with wash solution to desorb compound |
| 10/19/2004 | CA2059898C Biologically active bacillus thuringiensis isolates and gene encoding a coleopteran-active toxin |
| 10/19/2004 | CA1341459C Modified fibrinolytic enzymes |
| 10/17/2004 | CA2463344A1 Process for producing sporidiobolus ruineniae strains with improved coenzyme q10 production |
| 10/14/2004 | WO2004088322A1 MULTIPLEX SCREENING FOR LYSOSOMAL STORAGE DISORDERS (LSDs) |
| 10/14/2004 | WO2004088321A1 Method for the enrichment of target cells by use of cbds |
| 10/14/2004 | WO2004087937A1 A process for the production of l-amino acids using strains of the enterobacteriaceae family which overexpress the galp gene, coding for a galactose proton symporter |
| 10/14/2004 | WO2004087936A1 Method of producing 1,2-propanediol using klebsiella pneumoniae |
| 10/14/2004 | WO2004087924A2 Method for delivery of substances to intracellular microorganisms |
| 10/14/2004 | WO2004087917A1 Thioredoxin modification |
| 10/14/2004 | WO2004087909A1 Polynucleotide encoding 2-hydorxyisoflavanone dehydratase and application of the same |
| 10/14/2004 | WO2004087895A1 tdcBC/pckA GENE-INACTIVATED MICROORGANISM AND METHOD OF PRODUCING L-THREONINE USING THE SAME |
| 10/14/2004 | WO2004087894A2 Bacterial aggregates |
| 10/14/2004 | WO2004087891A1 Lactobacillus fermentum strain and uses thereof |
| 10/14/2004 | WO2004087890A2 A method of enhancing levels of polyunsaturated fatty acids in thraustochytrid protists |
| 10/14/2004 | WO2004087889A1 Mash viscosity reduction |
| 10/14/2004 | WO2004087764A1 Recombinant antibody recognizing dioxin and gene encoding the antibody |
| 10/14/2004 | WO2004076615A9 Immunomodulating probiotic compounds |
| 10/14/2004 | WO2004076492A3 Rubber treatment method |
| 10/14/2004 | WO2004065584A8 Storage stable frozen lactic acid bacteria culture |
| 10/14/2004 | WO2004056975A3 Increasing carotenoid production in bacteria via chromosomal integration |
| 10/14/2004 | WO2004024063A3 Compositions and methods for the diagnosis and treatment of tumor |
| 10/14/2004 | WO2004021010A3 Method of diagnosing colon and gastric cancers |
| 10/14/2004 | WO2004016740A3 Humanized rabbit antibodies |
| 10/14/2004 | WO2003099233A3 Microbial conversion of glucose to para-hydroxystyrene |
| 10/14/2004 | WO2003089620A3 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 10/14/2004 | WO2003087135A3 Novel pheromone receptor |
| 10/14/2004 | WO2003064592A3 Inhibitors of autoinducer transporters |
| 10/14/2004 | WO2003061595A3 Antibodies against and compositions containing new amphetamine derivatives |
| 10/14/2004 | WO2003052057A3 Egvi endoglucanase and nucleic acids encoding the same |
| 10/14/2004 | WO2003031475A8 Antibodies against kdr, their production and uses |
| 10/14/2004 | US20040204577 Novel peptide-forming enzyme gene |
| 10/14/2004 | US20040204575 Bovine lymphocyte-derived antibacterial protein |
| 10/14/2004 | US20040204563 Generating transgenic bacteria coding/expressing eschrichia thioredoxin fusion protein for use as diagnostic marker in heterologous gene expression; bioreactors |
| 10/14/2004 | US20040203157 Transfroming arabidopsis with expression vector coding genes associated with heat, freeze, salt and drought resistance; using ribonucleoproteins to control effivient gene transcription in plants; bioreactors |
| 10/14/2004 | US20040203153 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made |
| 10/14/2004 | US20040203144 Using calcium-activated chloride channels (CLCA) to identify modulators for treatment of bronchitis, asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and bronchiectasis |
| 10/14/2004 | US20040203134 involves the profound enzymatic protein hydrolysis of marine animal biomass, whereby cold-water fish wastes are reacted with viscera containing aggressive enzymes that are effective in even mild (slightly alkaline) medium of water |
| 10/14/2004 | US20040203130 Subtilisin variants |
| 10/14/2004 | US20040203129 having high specific activity and strong oxidant resistance, and having excellent detergency that is to be added to a detergent |
| 10/14/2004 | US20040203123 Method for transforming Amycolatopsis sp. DSM 9991 and DSM 9992 |
| 10/14/2004 | US20040203121 Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
| 10/14/2004 | US20040203120 by inoculating the protests into a culture medium, growing the culture for 2 to 5 days at room temperature, harvesting the cells by centrifugation to obtain biomass, storing the biomass at about 10 degrees C. for 12 to 48 hours |
| 10/14/2004 | US20040203119 synthase (PKS) system, comprising at least two modules, of said PKS, wherein said PKS has been modified to prevent its utilization of its native starter unit, but wherein said PKS is able to incorporate a diketide substrate into a polyketide that is at least a triketide |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040203116 IL-1 eta DNA and polypeptides |
| 10/14/2004 | US20040203113 Nucleic acids encoding beta 1,4-N-acetylgalactosaminyltransferases from C. jejuni |
| 10/14/2004 | US20040203112 Beta1,4-N-acetylgalactosaminyltransferases from C. jenuni |
| 10/14/2004 | US20040203111 UDP-N-acetylglucosamine: galactose-B1,3-N-acetylgalactosamine-a-R/ (GlcNAc to GalNAc) B1-6 N- acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203105 for drug screening emzyme inhibitors using genetically engineered animal models; for anticancer agents |
| 10/14/2004 | US20040203104 for drug screening enzyme inhibitors; genetic engineering; comprising subjecting the sample to a polymerase chain reaction, a northern hybridization assay or an in situ hybridization assay |
| 10/14/2004 | US20040203103 has both an alpha 2,3- and an alpha 2,8-activity; involved in synthesis of lipooligosaccharide (LOS); genetic engineering |
| 10/14/2004 | US20040203099 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 10/14/2004 | US20040203098 Compounds and methods for modulating activation of NF-kappaB |
| 10/14/2004 | US20040203097 Kinases and phosphatases |
| 10/14/2004 | US20040203095 from porcine pancreas in pichia pastoris which is soluble and secreted into the culture medium, whereby expression at pH 3.0-4.0 substantially prevents activation of trypsinogen to beta -trypsin and autolysis of beta-trypsin by alpha -trypsin |
| 10/14/2004 | US20040203093 Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof |
| 10/14/2004 | US20040203092 UDP-N-acetylglucosamine:galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203091 Process for synthesizing protein using cell-free protein synthesis system |